Skip to main content
HOPA Abstracts
Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib for Advanced or Metastatic Breast Cancer in a Real-World Setting
Abstract #CR17
Read More
HOPA Abstracts, PARP Inhibitors
Real-Life Study: Evaluation of the Safety of PARP Inhibitors in Ovarian Cancer at the Centre Hospitalier de l’Université de Montréal (CHUM)
Abstract #CR18
Read More
HOPA Abstracts
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy (the REMEDY Trial)
Abstract #CR19
Read More
HOPA Abstracts
Survey of PGY-2 Oncology Residency Program Directors to Assess Current Resources and Effects on Burnout
Abstract #CR20
Read More
HOPA Abstracts
Taxane Titration: To Prime or Not to Prime?
Abstract #CR21
Read More
HOPA Abstracts
Treatment and Outcomes Associated With Caplacizumab in the Management of Acquired Thrombotic Thrombocytopenic Purpura
Abstract #CR22
Read More
HOPA Abstracts
Pharmacist Interventions Resulting From a Health System Specialty Pharmacy 14-Day Oncology Check-In Protocol
Abstract #LB02
Read More
HOPA Abstracts
Comparison of the Efficacy of Generic Plerixafor Versus Mozobil as Adjunct Peripheral Blood Stem-Cell Mobilization Agents in Patients With Multiple Myeloma
Abstract #LB01
Read More
HOPA Abstracts, Methotrexate
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate vs Tacrolimus and Methotrexate as GVHD Prevention Following Allogeneic Stem Cell Transplant With Myeloablative Conditioning
Abstract #LB03
Read More
HOPA Abstracts
Real-World Clinical Outcomes With Fostamatinib for the Treatment of Refractory Chronic Immune Thrombocytopenia
Abstract #LB04
Read More
Page 22 of 197
Results 211 - 220 of 1963